Serglycin as a potential diagnostic biomarker for hemangiosarcoma in dogs
Hemangiosarcoma (HSA) is a common splenic malignant neoplasia in dogs, originating from the endothelium. The tumor has an aggressive character, and the clinical symptoms of HSA are mostly due to the secondary effects of the tumor such as tumor growth or rupture. The prognosis is poor for HSA, usu...
| Main Author: | |
|---|---|
| Format: | H3 |
| Language: | Inglés Swedish |
| Published: |
SLU/Dept. of Clinical Sciences (until 231231)
2022
|
| Subjects: |
Similar Items: Serglycin as a potential diagnostic biomarker for hemangiosarcoma in dogs
- Serglycin, en prognostisk biomarkör för aggressiv cancer i hund
- Use of dogs as odour detectors : a review of the scientific literture
- Hemangiosarkoms cellulära ursprung
- Quantitative polymerase chain reaction method compared with traditional methods for Clostridium tyrobutyricum in grass-clover silage
- Metodutveckling för analys av serglycinuttrycket i blodet hos hundar
- Methodologies for training detection dogs and scent sample storing